This platform overcomes major challenges in developing oral peptide therapeutics by addressing enzymatic degradation and poor gastrointestinal absorption through enhanced molecular stability and advanced formulation technologies.

The platform enables peptides to achieve clinically meaningful exposure by combining rational peptide design with innovative drug delivery strategies that significantly improve absorption across the gastrointestinal tract. This approach simultaneously addresses both peptide stability and absorption challenges, offers versatility across broad peptide structures and disease indications, and integrates proprietary technologies that create robust intellectual property protection.